These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27046049)

  • 41. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity.
    Peterson JL; Buskirk SJ; Heckman MG; Diehl NN; Bernard JR; Tzou KS; Casale HE; Bellefontaine LP; Serago C; Kim S; Vallow LA; Daugherty LC; Ko SJ
    Med Dosim; 2014; 39(1):12-7. PubMed ID: 24099966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.
    Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
    Radiat Oncol; 2016 Oct; 11(1):144. PubMed ID: 27799048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
    Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
    Cheung R; Tucker SL; Ye JS; Dong L; Liu H; Huang E; Mohan R; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1513-9. PubMed ID: 15050331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum.
    al-Abany M; Helgason AR; Cronqvist AK; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1035-44. PubMed ID: 15752882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
    van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancer.
    Kragelj B; Zlatic J; Zaletel-Kragelj L
    Brachytherapy; 2017; 16(1):193-200. PubMed ID: 27908678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.
    Hanlon AL; Schultheiss TE; Hunt MA; Movsas B; Peter RS; Hanks GE
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):59-63. PubMed ID: 9212005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statistical analysis of dose-volume profiles and its implication for radiation therapy planning in prostate carcinoma.
    Vanasek J; Odrazka K; Dolezel M; Kolarova I; Jarkovsky J; Pavlik T; Hlavka A; Dusek L
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):769-76. PubMed ID: 23628133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2000 Jan; 54(1):11-9. PubMed ID: 10719695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors.
    Alsadius D; Hedelin M; Lundstedt D; Pettersson N; Wilderäng U; Steineck G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e181-5. PubMed ID: 22677373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.
    Vavassori V; Fiorino C; Rancati T; Magli A; Fellin G; Baccolini M; Bianchi C; Cagna E; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Valdagni R
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1401-10. PubMed ID: 17241754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk.
    Vanneste BGL; van Wijk Y; Lutgens LC; Van Limbergen EJ; van Lin EN; van de Beek K; Lambin P; Hoffmann AL
    Strahlenther Onkol; 2018 Jan; 194(1):31-40. PubMed ID: 29038832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anal and rectal function after intensity-modulated prostate radiotherapy with endorectal balloon.
    Krol R; McColl GM; Hopman WPM; Smeenk RJ
    Radiother Oncol; 2018 Aug; 128(2):364-368. PubMed ID: 29716753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient-reported toxicity correlated to dose-volume histograms of the rectum in radiotherapy of the prostate.
    Taussky D; Schneider U; Rousson V; Pescia R
    Am J Clin Oncol; 2003 Oct; 26(5):e144-9. PubMed ID: 14528089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
    Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.